US Stock MarketDetailed Quotes

Evofem Biosciences (EVFMD)

Watchlist
  • 1.000000
  • 0.0000000.00%
15min DelayClose Oct 19 16:00 ET
1.99MMarket Cap-0.01P/E (TTM)

Evofem Biosciences (EVFMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
Total revenue
104.23%16.84M
-94.93%181K
272.14%6.37M
224.93%6.03M
284.71%4.25M
1,748.43%8.24M
2,025.00%3.57M
515.83%1.71M
1.86M
1.11M
Operating revenue
104.23%16.84M
-94.93%181K
272.14%6.37M
224.93%6.03M
284.71%4.25M
1,748.43%8.24M
2,025.00%3.57M
515.83%1.71M
--1.86M
--1.11M
Cost of revenue
8.88%4.42M
-78.12%384K
75.92%1.68M
53.16%1.29M
110.67%1.07M
766.45%4.06M
1,062.25%1.76M
201.26%955K
839K
506K
Gross profit
196.54%12.42M
-111.18%-203K
519.68%4.69M
366.50%4.75M
431.72%3.19M
19,140.91%4.19M
10,576.47%1.82M
2,041.03%757K
1.02M
599K
Operating expense
-43.54%96.55M
-69.80%11.85M
-46.94%23.42M
-30.82%29.17M
-29.37%32.11M
65.05%170.99M
9.38%39.23M
68.96%44.13M
88.45%42.16M
136.29%45.47M
Selling and administrative expenses
-48.13%71.51M
-66.77%10.16M
-48.60%18.21M
-36.34%21.42M
-43.15%21.72M
59.28%137.86M
2.18%30.57M
61.76%35.43M
70.55%33.65M
154.78%38.21M
-Selling and marketing expense
-61.16%43.95M
-71.91%7M
-60.79%11.95M
-54.85%12.3M
-58.38%12.71M
100.39%113.15M
4.22%24.92M
107.27%30.47M
172.45%27.24M
288.61%30.53M
-General and administrative expense
11.55%27.56M
-44.11%3.16M
26.29%6.26M
42.24%9.13M
17.36%9.02M
-17.87%24.71M
-5.93%5.65M
-31.15%4.96M
-34.09%6.42M
7.59%7.68M
Research and development costs
-24.44%25.03M
-80.48%1.69M
-40.16%5.21M
-8.97%7.74M
43.09%10.39M
94.30%33.13M
45.63%8.66M
106.33%8.7M
222.23%8.51M
70.99%7.26M
Operating profit
49.57%-84.12M
67.79%-12.05M
56.83%-18.72M
40.65%-24.42M
35.53%-28.93M
-60.97%-166.8M
-4.37%-37.42M
-65.81%-43.37M
-83.90%-41.14M
-133.17%-44.87M
Net non-operating interest income expense
466.67%85K
2,900.00%30K
1,566.67%50K
0.00%4K
-85.71%1K
-91.12%15K
-94.12%1K
-85.71%3K
-86.21%4K
-93.14%7K
Non-operating interest income
466.67%85K
2,900.00%30K
1,566.67%50K
0.00%4K
-85.71%1K
-91.12%15K
-94.12%1K
-85.71%3K
-86.21%4K
-93.14%7K
Other net income (expense)
119.24%7.39M
126.14%3.69M
452.48%108.19M
-1,414.67%-101.55M
-129.76%-2.96M
1.19%-38.39M
-196.75%-14.13M
-715.92%-30.7M
125.47%7.72M
-32,075.00%-1.29M
Gain on sale of security
128.14%9.47M
134.51%4.46M
468.17%108.63M
-1,235.02%-101.13M
-1,650.70%-2.49M
8.46%-33.66M
-250.14%-12.92M
-850.24%-29.51M
129.73%8.91M
---142K
Other non- operating income (expenses)
55.90%-2.09M
36.83%-765K
63.36%-436K
65.01%-415K
58.86%-471K
-127.28%-4.73M
-12.97%-1.21M
-81.13%-1.19M
-239.83%-1.19M
-28,525.00%-1.15M
Income before tax
62.64%-76.65M
83.84%-8.33M
220.87%89.52M
-276.97%-125.96M
30.91%-31.89M
-44.18%-205.18M
-26.98%-51.55M
-147.72%-74.06M
36.55%-33.41M
-141.05%-46.15M
Income tax
158.82%44K
33.33%8K
13K
66.67%20K
400.00%3K
325.00%17K
200.00%6K
0
12K
-1K
Net income
62.62%-76.7M
83.83%-8.34M
220.85%89.51M
-276.89%-125.98M
30.91%-31.89M
-44.19%-205.19M
-26.99%-51.55M
-147.70%-74.06M
36.53%-33.43M
-141.05%-46.15M
Net income continuous Operations
62.62%-76.7M
83.83%-8.34M
220.85%89.51M
-276.89%-125.98M
30.91%-31.89M
-44.19%-205.19M
-26.99%-51.55M
-147.70%-74.06M
36.53%-33.43M
-141.05%-46.15M
Minority interest income
Net income attributable to the parent company
62.62%-76.7M
83.83%-8.34M
220.85%89.51M
-276.89%-125.98M
30.91%-31.89M
-44.19%-205.19M
-26.99%-51.55M
-147.70%-74.06M
36.53%-33.43M
-141.05%-46.15M
Preferred stock dividends
25.69%1.32M
3.14M
-1.91M
81K
1.05M
Other preferred stock dividends
Net income attributable to common stockholders
62.17%-78.01M
78.18%-11.48M
220.85%89.51M
-271.18%-124.07M
30.73%-31.97M
-44.92%-206.24M
-29.57%-52.6M
-147.70%-74.06M
36.53%-33.43M
-141.05%-46.15M
Basic earnings per share
94.33%-167.5
98.12%-11.6563
115.14%136.25
-13.97%-571.25
65.96%-360.1782
25.69%-2.95K
34.00%-618.7469
-29.73%-900
70.62%-501.25
-41.07%-1.06K
Diluted earnings per share
94.33%-167.5
98.12%-11.6563
99.44%-5
-13.97%-571.25
65.96%-360.1782
25.69%-2.95K
34.00%-618.7469
-29.73%-900
70.62%-501.25
-41.07%-1.06K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021
Total revenue 104.23%16.84M-94.93%181K272.14%6.37M224.93%6.03M284.71%4.25M1,748.43%8.24M2,025.00%3.57M515.83%1.71M1.86M1.11M
Operating revenue 104.23%16.84M-94.93%181K272.14%6.37M224.93%6.03M284.71%4.25M1,748.43%8.24M2,025.00%3.57M515.83%1.71M--1.86M--1.11M
Cost of revenue 8.88%4.42M-78.12%384K75.92%1.68M53.16%1.29M110.67%1.07M766.45%4.06M1,062.25%1.76M201.26%955K839K506K
Gross profit 196.54%12.42M-111.18%-203K519.68%4.69M366.50%4.75M431.72%3.19M19,140.91%4.19M10,576.47%1.82M2,041.03%757K1.02M599K
Operating expense -43.54%96.55M-69.80%11.85M-46.94%23.42M-30.82%29.17M-29.37%32.11M65.05%170.99M9.38%39.23M68.96%44.13M88.45%42.16M136.29%45.47M
Selling and administrative expenses -48.13%71.51M-66.77%10.16M-48.60%18.21M-36.34%21.42M-43.15%21.72M59.28%137.86M2.18%30.57M61.76%35.43M70.55%33.65M154.78%38.21M
-Selling and marketing expense -61.16%43.95M-71.91%7M-60.79%11.95M-54.85%12.3M-58.38%12.71M100.39%113.15M4.22%24.92M107.27%30.47M172.45%27.24M288.61%30.53M
-General and administrative expense 11.55%27.56M-44.11%3.16M26.29%6.26M42.24%9.13M17.36%9.02M-17.87%24.71M-5.93%5.65M-31.15%4.96M-34.09%6.42M7.59%7.68M
Research and development costs -24.44%25.03M-80.48%1.69M-40.16%5.21M-8.97%7.74M43.09%10.39M94.30%33.13M45.63%8.66M106.33%8.7M222.23%8.51M70.99%7.26M
Operating profit 49.57%-84.12M67.79%-12.05M56.83%-18.72M40.65%-24.42M35.53%-28.93M-60.97%-166.8M-4.37%-37.42M-65.81%-43.37M-83.90%-41.14M-133.17%-44.87M
Net non-operating interest income expense 466.67%85K2,900.00%30K1,566.67%50K0.00%4K-85.71%1K-91.12%15K-94.12%1K-85.71%3K-86.21%4K-93.14%7K
Non-operating interest income 466.67%85K2,900.00%30K1,566.67%50K0.00%4K-85.71%1K-91.12%15K-94.12%1K-85.71%3K-86.21%4K-93.14%7K
Other net income (expense) 119.24%7.39M126.14%3.69M452.48%108.19M-1,414.67%-101.55M-129.76%-2.96M1.19%-38.39M-196.75%-14.13M-715.92%-30.7M125.47%7.72M-32,075.00%-1.29M
Gain on sale of security 128.14%9.47M134.51%4.46M468.17%108.63M-1,235.02%-101.13M-1,650.70%-2.49M8.46%-33.66M-250.14%-12.92M-850.24%-29.51M129.73%8.91M---142K
Other non- operating income (expenses) 55.90%-2.09M36.83%-765K63.36%-436K65.01%-415K58.86%-471K-127.28%-4.73M-12.97%-1.21M-81.13%-1.19M-239.83%-1.19M-28,525.00%-1.15M
Income before tax 62.64%-76.65M83.84%-8.33M220.87%89.52M-276.97%-125.96M30.91%-31.89M-44.18%-205.18M-26.98%-51.55M-147.72%-74.06M36.55%-33.41M-141.05%-46.15M
Income tax 158.82%44K33.33%8K13K66.67%20K400.00%3K325.00%17K200.00%6K012K-1K
Net income 62.62%-76.7M83.83%-8.34M220.85%89.51M-276.89%-125.98M30.91%-31.89M-44.19%-205.19M-26.99%-51.55M-147.70%-74.06M36.53%-33.43M-141.05%-46.15M
Net income continuous Operations 62.62%-76.7M83.83%-8.34M220.85%89.51M-276.89%-125.98M30.91%-31.89M-44.19%-205.19M-26.99%-51.55M-147.70%-74.06M36.53%-33.43M-141.05%-46.15M
Minority interest income
Net income attributable to the parent company 62.62%-76.7M83.83%-8.34M220.85%89.51M-276.89%-125.98M30.91%-31.89M-44.19%-205.19M-26.99%-51.55M-147.70%-74.06M36.53%-33.43M-141.05%-46.15M
Preferred stock dividends 25.69%1.32M3.14M-1.91M81K1.05M
Other preferred stock dividends
Net income attributable to common stockholders 62.17%-78.01M78.18%-11.48M220.85%89.51M-271.18%-124.07M30.73%-31.97M-44.92%-206.24M-29.57%-52.6M-147.70%-74.06M36.53%-33.43M-141.05%-46.15M
Basic earnings per share 94.33%-167.598.12%-11.6563115.14%136.25-13.97%-571.2565.96%-360.178225.69%-2.95K34.00%-618.7469-29.73%-90070.62%-501.25-41.07%-1.06K
Diluted earnings per share 94.33%-167.598.12%-11.656399.44%-5-13.97%-571.2565.96%-360.178225.69%-2.95K34.00%-618.7469-29.73%-90070.62%-501.25-41.07%-1.06K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More